BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16484853)

  • 1. [Progress in therapy for testicular tumors].
    Mizutani Y; Nakamura T; Nomoto T; Kawauchi A; Miki T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):183-7. PubMed ID: 16484853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
    Farmakis D; Pectasides M; Pectasides D
    Eur Urol; 2005 Sep; 48(3):400-7. PubMed ID: 15964136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["State-of-the-art" chemotherapy for small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():398-404. PubMed ID: 9369914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.
    Green MR
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiation in locally advanced non-small cell lung cancer.
    Bonomi P; Shirazi W
    Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outpatient chemotherapy for lung cancer].
    Yoneda S
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):533-7. PubMed ID: 17431337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy for advanced non-small cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):770-6. PubMed ID: 15984514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel in the management of advanced pancreatic cancer.
    Lopes G; Rocha Lima CM
    Semin Oncol; 2005 Apr; 32(2 Suppl 4):S10-23. PubMed ID: 16015551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with docetaxel in the treatment of gastric cancer.
    Philip PA
    Semin Oncol; 2005 Apr; 32(2 Suppl 4):S24-38. PubMed ID: 16015552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
    Mavroudis D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
    Einhorn LH; Brames MJ; Juliar B; Williams SD
    J Clin Oncol; 2007 Feb; 25(5):513-6. PubMed ID: 17290059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Developed new agents for lung cancer].
    Kato Y; Saijo N
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG).
    Bokemeyer C; Kollmannsberger C; Harstrick A; Beyer J; Gerl A; Casper J; Metzner B; Hartmann JT; Schmoll HJ; Kanz L
    Int J Cancer; 1999 Dec; 83(6):848-51. PubMed ID: 10597209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 patients.
    Elsing C; Herrmann C; Hannig CV; Stremmel W; Jäger D; Herrmann T
    Oncology; 2013; 85(5):262-8. PubMed ID: 24192723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs for treating small cell lung cancer.
    Ettinger DS
    Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
    Heinemann V
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
    Kulke MH; Tempero MA; Niedzwiecki D; Hollis DR; Kindler HL; Cusnir M; Enzinger PC; Gorsch SM; Goldberg RM; Mayer RJ
    J Clin Oncol; 2009 Nov; 27(33):5506-12. PubMed ID: 19858396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.